J Exp Med:SARS-CoV-2可感染神经细胞,并导致组织损伤

2021-01-21 MedSci原创 MedSci原创

一个科学家小组最近一项研究提供了SARS-CoV-2可以直接感染中枢神经系统(CNS)中的细胞,并导致组织损伤的证据。

一个科学家小组最近一项研究提供了SARS-CoV-2可以直接感染中枢神经系统(CNS)中的细胞,并导致组织损伤的证据。

SARS-CoV-2通过与细胞表面血管紧张素转换酶II(ACE-2)受体结合而感染肺组织。一旦病毒与细胞结合,病毒就可以进入细胞,引起呼吸系统症状,如呼吸急促和干咳。

然而,最近的研究表明,这种病毒也可以感染中枢神经系统的细胞,并且可阻碍中枢神经系统的血液流动。这项研究于1月12日发表于《实验医学杂志(Journal of Experimental Medicine)》

这项研究可以解释为什么COVID-19患者会产生头晕、神志不清、中风和昏迷等神经系统症状。

研究小组使用了三种不同的大脑模型:人脑类器官、基因工程小鼠以及对已死亡的COVID-19患者进行尸检。

首先,利用人脑类器官,研究人员找到了人脑感染的明确证据,且发现感染伴随邻近神经元的代谢变化,但并没有证据显示产生了I型干扰素应答。他们还发现用抗体阻断ACE-2受体或给予COVID-19患者脑脊液可以预防神经元感染。

研究人员还观察到人脑类器官在特定的脑区积聚了SARS-CoV-2阳性细胞,这为病毒感染神经元并自我复制提供了证据。

电镜下人脑类器官中的SARS-CoV-2病毒

其次,研究人员利用过度表达人ACE-2的小鼠模型证明了SARS-CoV-2在体内可侵袭神经细胞。

研究人员在SARS-CoV-2病毒感染小鼠脑中检测到高水平的受感染神经细胞,且与血管的显著变化有关,这些变化可能会破坏大脑内的氧气流动。

最后,研究人员检查了三名死于严重COVID-19并发症的患者的大脑,这三明患者都有过呼吸衰竭,并被送入重症监护室的经历。

在受感染的大脑区域内,有组织损伤和细胞死亡的迹象,表现为缺血性梗死。

阳性病毒染色主要出现在梗死边缘周围

研究还发现,尽管SARS-CoV-2具有嗜神经特性,可以感染患者的神经元,但它并没有像其他嗜神经病毒那样引起典型免疫反应。

原始出处:Eric Song, Ce Zhang, Benjamin Israelow, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. Journal of Experimental Medicine. January 12 2021

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1688807, encodeId=d9d9168880e44, content=<a href='/topic/show?id=8667e769859' target=_blank style='color:#2F92EE;'>#组织损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77698, encryptionId=8667e769859, topicName=组织损伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7fe28645771, createdName=小几洁, createdTime=Sat May 15 07:37:04 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937984, encodeId=98a6193e98471, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Feb 13 07:37:04 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321250, encodeId=025813212507b, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398087, encodeId=e461139808e26, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489564, encodeId=aa381489564d3, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610866, encodeId=7daa161086619, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1688807, encodeId=d9d9168880e44, content=<a href='/topic/show?id=8667e769859' target=_blank style='color:#2F92EE;'>#组织损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77698, encryptionId=8667e769859, topicName=组织损伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7fe28645771, createdName=小几洁, createdTime=Sat May 15 07:37:04 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937984, encodeId=98a6193e98471, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Feb 13 07:37:04 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321250, encodeId=025813212507b, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398087, encodeId=e461139808e26, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489564, encodeId=aa381489564d3, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610866, encodeId=7daa161086619, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-02-13 hukaixun
  3. [GetPortalCommentsPageByObjectIdResponse(id=1688807, encodeId=d9d9168880e44, content=<a href='/topic/show?id=8667e769859' target=_blank style='color:#2F92EE;'>#组织损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77698, encryptionId=8667e769859, topicName=组织损伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7fe28645771, createdName=小几洁, createdTime=Sat May 15 07:37:04 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937984, encodeId=98a6193e98471, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Feb 13 07:37:04 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321250, encodeId=025813212507b, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398087, encodeId=e461139808e26, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489564, encodeId=aa381489564d3, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610866, encodeId=7daa161086619, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 小刀医生
  4. [GetPortalCommentsPageByObjectIdResponse(id=1688807, encodeId=d9d9168880e44, content=<a href='/topic/show?id=8667e769859' target=_blank style='color:#2F92EE;'>#组织损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77698, encryptionId=8667e769859, topicName=组织损伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7fe28645771, createdName=小几洁, createdTime=Sat May 15 07:37:04 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937984, encodeId=98a6193e98471, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Feb 13 07:37:04 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321250, encodeId=025813212507b, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398087, encodeId=e461139808e26, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489564, encodeId=aa381489564d3, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610866, encodeId=7daa161086619, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1688807, encodeId=d9d9168880e44, content=<a href='/topic/show?id=8667e769859' target=_blank style='color:#2F92EE;'>#组织损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77698, encryptionId=8667e769859, topicName=组织损伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7fe28645771, createdName=小几洁, createdTime=Sat May 15 07:37:04 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937984, encodeId=98a6193e98471, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Feb 13 07:37:04 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321250, encodeId=025813212507b, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398087, encodeId=e461139808e26, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489564, encodeId=aa381489564d3, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610866, encodeId=7daa161086619, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1688807, encodeId=d9d9168880e44, content=<a href='/topic/show?id=8667e769859' target=_blank style='color:#2F92EE;'>#组织损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77698, encryptionId=8667e769859, topicName=组织损伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7fe28645771, createdName=小几洁, createdTime=Sat May 15 07:37:04 CST 2021, time=2021-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1937984, encodeId=98a6193e98471, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sat Feb 13 07:37:04 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321250, encodeId=025813212507b, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398087, encodeId=e461139808e26, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489564, encodeId=aa381489564d3, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610866, encodeId=7daa161086619, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jan 23 08:37:04 CST 2021, time=2021-01-23, status=1, ipAttribution=)]

相关资讯

先声药业赴港交所上市,3款重点产品有望在未来两年上市!

香港证券交易所最新公告,先声药业已提交上市申请。

早期肺癌辅助治疗!奥希替尼新适应症上市申请获FDA优先审评资格

阿斯利康宣布FDA接受其提交的奥希替尼补充新药申请(sNDA),并授予优先审评资格,用于对接受过完全肿瘤切除术的早期(IB、II和IIIA期)表皮生长因子受体突变(EGFRm)非小细胞肺癌(NSCLC

Nat Neurosci :免疫细胞加速正常人脑衰老

衰老是生命过程的必经阶段,而中枢神经系统是人体受衰老影响最大的系统之一。目前,与脑衰老相关的认知功能减退已成为老年人健康的巨大威胁。

Nature:壁龛僵硬促进中枢神经系统祖细胞老化

衰老引起组织再生能力减弱,主要是因为成体干细胞和祖细胞群体的功能丧失。例如,广泛分布的数量丰富的中枢神经系统(CNS)多能干细胞——少突胶质祖细胞(OPCs)的再生能力明显降低。这种功能丧失的一个相对被忽视的潜在来源是干细胞"壁龛"——一组细胞外信号,包括化学信号和机械信号。研究人员发现OPC微环境随着年龄的增长而僵硬,该机制改变有效引起年龄相关的OPCs功能丧失。采用生物和合成的支架来模拟年轻大

Sci Transl Med:活化的白细胞黏附分子调控B淋巴细胞穿越血脑屏障

多发性硬化(MS)是一种中枢神经系统的慢性自身免疫病,是年轻人非创伤性神经障碍的主要原因。脑脊液中出现B淋巴细胞相关的寡克隆免疫球蛋白是M)的典型特征。

Nat Immunol :科学家发现一种新型细胞,可促进中枢神经系统再生!

神经退行性疾病是由神经元或其髓鞘的丧失导致人体出现功能障碍的中枢神经系统疾病,包括创伤性脑或脊髓损伤(SCI)、多发性硬化症和运动神经元疾病等。